Roche Holding Overview

  • Founded
  • 1896
Founded
  • Status
  • Public
  • Employees
  • 97,735
Employees
  • Stock Symbol
  • ROG
Stock Symbol
  • Investments
  • 77
  • Share Price
  • $334.42
  • (As of Friday Closing)

Roche Holding General Information

Description

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and professional diagnostics for more than half of diagnostic-related sales.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Drug Delivery
Stock Exchange
SWX
Primary Office
  • Grenzacherstrasse 124
  • Konzern Hauptsitz
  • 4070 Basel
  • Switzerland
+41 061 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Holding Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$334.42 $335.10 $280.63 - $380.25 $286B 855M 1.93M $15.50

Roche Holding Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 301,931,176 287,991,047 225,095,871 232,206,530
Revenue 61,681,248 61,855,068 58,089,107 54,134,842
EBITDA 21,815,298 21,734,711 18,877,989 17,134,558
Net Income 13,258,634 13,582,434 10,729,614 8,768,384
Total Assets 84,493,907 85,755,421 79,749,934 78,715,519
Total Debt 15,816,257 16,081,657 19,064,741 19,464,321
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Roche Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche Holding‘s full profile, request access.

Request a free trial

Roche Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a var
Pharmaceuticals
Basel, Switzerland
97,735 As of 2019
00000
00.00 0000-00-00
00000000000

00000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mini
000000000000000
Tokyo, Japan
00000 As of 0000
000000000000

00000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
000000000000000
Staines-Upon-Thames, United Kingdom
0000 As of 0000
00.00
0&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Roche Holding Competitors (42)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Astellas Pharma Corporate Backed or Acquired Tokyo, Japan 00000 000000000000
000000000000 Corporation Staines-Upon-Thames, United Kingdom 0000 00.00 0&0
00000000000 Formerly PE-Backed Cambridge, United Kingdom 00000 000 00000000 000
00000 000000000 Formerly VC-backed Burlington, MA 00000 000000&0
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000000 000.00
You’re viewing 5 of 42 competitors. Get the full list »

Roche Holding Executive Team (31)

Name Title Board Seat Contact Info
Severin Schwan Chief Executive Officer & Member of the Board of Directors
Alan Hippe JD Chief Financial and IT Officer
James Sabry Ph.D Managing Director & Global Head
Frank Fanien Ph.D Head of Digital Health Solutions Roche Diagnostics CPS & Senior Vice President
Gottlieb Keller JD General Counsel & Secretary, Board of Directors
You’re viewing 5 of 31 executive team members. Get the full list »

Roche Holding Board Members (13)

Name Representing Role Since
0000é 00000000 Roche Holding Vice Chairman 000 0000
0000000 0000 Roche Holding Board Member 000 0000
0000000 0000000 Roche Holding Member Board of Directors 000 0000
000000000 00000 Self Chairman 000 0000
0000000 0000000000 00.0 Roche Holding Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Roche Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Roche Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche Holding‘s full profile, request access.

Request a free trial

Roche Holding Investments & Acquisitions (77)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0000000 07-Oct-2020 000000000 00000 00 000.00 Buildings and Property 00000 00000 00.0
0000000 00000000 22-May-2020 000000000000000000 Biotechnology
000000000 13-Feb-2020 000000000000000000 00.000 Drug Discovery
0000000 0000000000 23-Dec-2019 000000000 00000 00 00.000 Buildings and Property 0000000 000000
Spark Therapeutics 17-Dec-2019 Merger/Acquisition 00.00 Biotechnology 0000000 000000
You’re viewing 5 of 77 investments and acquisitions. Get the full list »

Roche Holding Subsidiaries (20)

Company Name Industry Location Founded
Spark Therapeutics Biotechnology Philadelphia, PA 2013
00000000 Enterprise Systems (Healthcare) New York, NY 0000
000000 Information Services (B2C) Vienna, Austria 0000
0000000000 0000000 Diagnostic Equipment Cambridge, MA 0000
00000 000000000000 Biotechnology Mountain View, CA 0000
You’re viewing 5 of 20 subsidiaries. Get the full list »

Roche Holding Exits (14)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 24-Sep-2014 00000 00000 00 0000 Completed
  • 9 buyers
000000000 00000000 17-Dec-2012 000000000 Completed
  • 00000 0000000
0000 0000000000000 14-Sep-2012 00000 00000 00 000 Completed
  • 6 buyers
000000 0000000 20-Dec-2010 000000000000000000 00000 Completed
  • 00000 0000000
SWISSLAB DITS 19-Nov-2008 Merger/Acquisition Completed
You’re viewing 5 of 14 exits. Get the full list »